Epinephrine 0.3 Adults Injection
Product Images NDC 70385-2019

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Epinephrine 0.3 Adults (NDC 70385-2019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sina Health Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epinephrine Structrual Formula (Image 01)

Chemical structure of epinephrine showing a benzene ring with three hydroxyl groups and an attached side chain with amine functional group. This structural diagram represents the active ingredient epinephrine.*

FDA Label Image

Figure A (Image 02)

Illustration showing two epinephrine auto-injectors: one labeled as 0.3 mg with a yellow label, yellow cap, blue safety top, protective case, medicine viewing window, expiration date, and orange needle end; the other labeled as 0.15 mg with a green label, green cap, blue safety top, medicine viewing window, and orange needle end.*

FDA Label Image

Figure B (Image 03)

An anatomical illustration showing the injection sites for Epinephrine 0.3 Adults intramuscular injection. The diagram depicts the front view of the upper legs, highlighting the preferred areas on both outer thighs labeled as 'Injection Site' with green shading.*

FDA Label Image

Figure C (Image 04)

An instructional illustration showing a hand holding an injection device with the thumb pressing down on the top, demonstrating how to administer the Epinephrine 0.3 Adults injection intramuscularly.*

FDA Label Image

Figure D And Figure E (Image 05)

An instructional diagram comparing two states of an epinephrine auto-injector safety top. The left image shows a blue safety top that is not raised, indicating the Epinephrine injection, USP auto-injector is okay to use. The right image shows a blue safety top that is raised, indicating the auto-injector should not be used and should be replaced.*

FDA Label Image

Figure F (Image 06)

Epinephrine 0.3 Adults training injector syringe labeled for practice use only, featuring a blue tip and orange safety label. The syringe includes instructions on how to treat an adult with a trainer. The product is for intramuscular injection and is marked as a no medicine trainer provided by Sina Health Inc.*

FDA Label Image

Figure G (Image 07)

An instructional illustration showing a syringe with a hidden needle feature. The top image depicts the syringe before use with the needle concealed, and the bottom image shows the syringe after use with the needle still hidden. Arrows and labels indicate the status of the needle before and after use. This likely relates to safety features in the Epinephrine 0.3 Adults injection device.*

FDA Label Image

Figure H (Image 08)

Packaging label for Epinephrine 0.3 Adults injection, 0.3 mg/0.3 mL, an intramuscular injection. The label shows usage instructions and contains a depiction of the autoinjector device. The labeler is Sina Health Inc, and the product NDC is 70385-2019.*

FDA Label Image

Figure I (Image 09)

An instructional illustration showing two hands holding an epinephrine autoinjector pen. One hand grips the yellow device while the other hand removes the blue safety cap from the opposite end, demonstrating preparation for intramuscular injection.*

FDA Label Image

Figure J (Image 10)

An instructional illustration showing how to remove the blue safety top from an epinephrine injection pen before use. The diagram includes an arrow pointing up to indicate pulling off the safety top, and labels the needle end of the device. The image is presented in black and white with green and orange highlights.*

FDA Label Image

Figure K (Image 11)

An instructional illustration showing a person holding an epinephrine injector against their outer thigh. Text instructs to "Push hard against leg," wait for a "pop" sound, and then "Hold 1-2-3 seconds." This demonstrates proper intramuscular injection technique for Epinephrine 0.3 Adults.*

FDA Label Image

Figure L (Image 12)

Instructional illustration showing how to use the Epinephrine 0.3 Adults injection. The image depicts a person pressing the injector hard against the leg, with an arrow indicating the motion and text instructing to hold for 1-3 seconds after a popping sound.*

FDA Label Image

Figure M (Image 13)

An instructional diagram showing a person holding an injection device near the hip area, indicating an intramuscular injection technique with an arrow pointing outward from the thigh. The image demonstrates how to position and administer the Epinephrine 0.3 Adults injection intramuscularly.*

FDA Label Image

Figure A (Image 14)

An instructional illustration labeled 'Figure A. Your Gray Trainer' showing a gray epinephrine trainer injector. The image highlights key parts of the trainer including a blue safety top, which should not be removed until ready to use, and an orange end.*

FDA Label Image

Figure B (Image 15)

Instructional illustration showing how to remove the blue safety top from the injection device. The image highlights using one hand to pull off the blue safety cap with an upward arrow and points out the orange end of the injector. This is related to the Epinephrine 0.3 Adults intramuscular injection device.*

FDA Label Image

Figure C (Image 16)

Illustration showing how to use Epinephrine 0.3 Adults injection intramuscularly by pushing the device hard against the outer thigh. The image includes the text instruction to hold for 1 to 3 seconds after the 'pop' sound to ensure proper administration.*

FDA Label Image

Figure D (Image 17)

An instructional illustration showing a hand pushing an injection device hard against the leg, accompanied by on-screen text advising to hold for 1-3 seconds after a popping sound is heard. This diagram demonstrates proper intramuscular injection technique for epinephrine administration.*

FDA Label Image

Figure E (Image 18)

An instructional diagram showing a device part labeled 'Check if used' with an orange end extending from a primarily gray cylinder, indicating use status of a product component.*

FDA Label Image

Figure F (Image 19)

An instructional illustration showing a hand holding an injector device with an orange tip, positioned above a flat surface with arrows indicating the direction to press or activate the injector device, typically used for intramuscular injection.*

FDA Label Image

Epinephrine Injection 0.3 mg Carton Label (Image 20)

Packaging label for Epinephrine Injection, USP Single-Dose Auto-Injector 0.3 mg by Sina Health Inc. The label shows two 0.3 mg auto-injectors in protective cases, a gray trainer, and includes instructions for use with illustrations detailing injection site, how to hold, and steps to administer the injection. The label highlights that the product is Rx only and intended for allergic emergencies (anaphylaxis).*

FDA Label Image

Epinephrine Injection 0.15 mg Carton Label (Image 21)

Packaging label for Epinephrine Injection, USP Single-Dose Auto-Injector 0.15 mg by Mylan, designed for allergic emergencies (anaphylaxis). The carton contains 2 units of the injection in protective cases along with a trainer device. The label includes usage instructions, storage information, and a QR code for additional information.*

FDA Label Image

Important Differences (Image 22)

Illustrations showing Epinephrine Injection, USP Auto-Injectors in two strengths: 0.3 mg and 0.15 mg. The images include the auto-injectors inside and removed from their carrier tubes, along with a trainer device labeled for practice only. The devices feature color-coded ends (orange for 0.3 mg, green for 0.15 mg) and basic usage instructions printed on the side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.